Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-08 Purchase | 2021-12-09 4:09 pm | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 28,700 | $0.677 | $19,430 | 37,186 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-01 Option Award | 2022-08-03 4:30 pm | N/A 2022-08-02 | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 960,347 | $0 | 997,533 (Direct) | View |
| 2021-04-29 Other | 2021-04-29 4:06 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 8 | $0 | 8,494 (Direct) | View |
| 2021-04-29 Conversion | 2021-04-29 4:06 pm | 2016-04-29 N/A | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 4,688 | $0 | 8,494 (Direct) | View |
| 2021-03-31 Other | 2021-03-31 4:08 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,562 (Direct) | View |
| 2020-12-31 Other | 2021-01-04 08:00 am | N/A N/A | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,540 (Direct) | View |
| 2020-09-30 Other | 2020-09-30 4:06 pm | N/A N/A | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,518 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-17 9:12 pm | N/A 2030-09-15 | Kintara Therapeutics Inc. | KTRA | Praill Anthony Scott Chief Financial Officer | 606,557 | $0 | 606,557 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-30 4:17 pm | N/A 2029-09-05 | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 57,170 | $0 | 115,862 (Direct) | View |
| 2020-06-30 Other | 2020-06-30 4:17 pm | N/A N/A | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 115,862 (Direct) | View |
| 2020-03-31 Other | 2020-03-31 4:28 pm | N/A N/A | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,474 (Direct) | View |
| 2019-12-31 Other | 2020-01-02 4:17 pm | N/A N/A | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,452 (Direct) | View |
| 2019-09-30 Other | 2019-10-01 4:14 pm | N/A N/A | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,430 (Direct) | View |
| 2019-09-05 Option Award | 2019-09-09 4:34 pm | N/A 2029-09-05 | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 108,366 | $0 | 108,366 (Direct) | View |
| 2019-06-28 Other | 2019-07-01 4:21 pm | N/A N/A | DelMar Pharmaceuticals Inc. | DMPI | Praill Anthony Scott Chief Financial Officer | 22 | $0 | 7,408 (Direct) | View |